Roy  Winston net worth and biography

Roy Winston Biography and Net Worth

Insider of Pacira BioSciences
Roy Winston joined Pacira in 2017 and serves as Chief Medical Officer. Dr. Winston will oversee research and development and all customer facing medical operations in addition to medical strategy. Prior to being named Chief Medical Officer, Dr. Winston served as Chief Clinical Officer. He practiced anesthesiology and critical care medicine for over twenty-five years, and prior to joining Pacira full time, was chair of Anesthesiology at Palm Beach Children’s Hospital and St. Mary’s Medical Center. Dr. Winston has been on the faculty of The University of California at Irvine, Emory University and Florida State University and is a board-certified anesthesiologist. Dr. Winston served on The Georgia Composite State Board of Medical Examiners as Vice President and President Elect and worked with the legislature to create and modify healthcare policy. He is the founder of LaserAway, a national aesthetic dermatology group, and served as its chief executive officer from January 2005 until March 2007. Dr. Winston has served as CEO and president of LaserAway Medical Corp., the management group of LaserAway, since January 2005. Dr. Winston is an honorably discharged veteran of the U.S. Navy and received his Bachelor of Arts from the University of Pennsylvania and his medical degree from the Icahn School of Medicine at Mount Sinai. He completed his residency training in anesthesiology at The University of Florida.

What is Roy Winston's net worth?

The estimated net worth of Roy Winston is at least $870,504.00 as of August 2nd, 2023. Dr. Winston owns 52,440 shares of Pacira BioSciences stock worth more than $870,504 as of November 17th. This net worth approximation does not reflect any other assets that Dr. Winston may own. Learn More about Roy Winston's net worth.

How do I contact Roy Winston?

The corporate mailing address for Dr. Winston and other Pacira BioSciences executives is 5 SYLVAN WAY SUITE 300, PARSIPPANY NJ, 07054. Pacira BioSciences can also be reached via phone at (813) 553-6680 and via email at [email protected]. Learn More on Roy Winston's contact information.

Has Roy Winston been buying or selling shares of Pacira BioSciences?

Roy Winston has not been actively trading shares of Pacira BioSciences during the past quarter. Most recently, Roy Winston sold 509 shares of the business's stock in a transaction on Wednesday, August 2nd. The shares were sold at an average price of $34.88, for a transaction totalling $17,753.92. Following the completion of the sale, the insider now directly owns 52,440 shares of the company's stock, valued at $1,829,107.20. Learn More on Roy Winston's trading history.

Who are Pacira BioSciences' active insiders?

Pacira BioSciences' insider roster includes Donald Manning (Insider), Max Reinhardt (Insider), Charles Reinhart, III (CFO), Lauren Riker (VP), David Stack (CEO), Andreas Wicki (Director), Kristen Williams (Insider), and Roy Winston (Insider). Learn More on Pacira BioSciences' active insiders.

Are insiders buying or selling shares of Pacira BioSciences?

In the last twelve months, Pacira BioSciences insiders bought shares 3 times. They purchased a total of 11,176 shares worth more than $136,240.40. In the last twelve months, insiders at the sold shares 10 times. They sold a total of 113,661 shares worth more than $3,413,175.87. The most recent insider tranaction occured on September, 13th when COO Daryl Gaugler sold 500 shares worth more than $6,430.00. Insiders at Pacira BioSciences own 6.4% of the company. Learn More about insider trades at Pacira BioSciences.

Information on this page was last updated on 9/13/2024.

Roy Winston Insider Trading History at Pacira BioSciences

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/2/2023Sell509$34.88$17,753.9252,440View SEC Filing Icon  
6/6/2023Sell1,779$38.99$69,363.2143,213View SEC Filing Icon  
8/3/2022Sell476$55.70$26,513.2044,992View SEC Filing Icon  
6/6/2022Sell17,546$61.39$1,077,148.9435,160View SEC Filing Icon  
6/4/2021Sell2,276$61.04$138,927.0424,035View SEC Filing Icon  
3/31/2021Sell22,224$70.61$1,569,236.6448,535View SEC Filing Icon  
11/13/2020Sell5,000$62.00$310,000.00View SEC Filing Icon  
3/11/2020Buy2,500$36.50$91,250.00View SEC Filing Icon  
See Full Table

Roy Winston Buying and Selling Activity at Pacira BioSciences

This chart shows Roy Winston's buying and selling at Pacira BioSciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Pacira BioSciences Company Overview

Pacira BioSciences logo
Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce controlled doses of cold temperature to targeted nerves. It has a development and commercialization, and supply agreement with Aratana Therapeutics, Inc. for NOCITA, a bupivacaine liposome injectable suspension product. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida.
Read More

Today's Range

Now: $16.60
Low: $16.21
High: $16.66

50 Day Range

MA: $15.81
Low: $12.73
High: $17.70

2 Week Range

Now: $16.60
Low: $11.16
High: $35.95

Volume

780,465 shs

Average Volume

535,337 shs

Market Capitalization

$766.42 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.82